ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,960Medicare Part D Prescriptions Filled, Including Refills

Rank: 298 out of 3647

$642K Total Retail Price of All Prescriptions

Rank: 672 out of 3647

1,054 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,054 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 1,054 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 14,256 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,262 1,073 1 1
LISINOPRIL 830 677 2 4
AMLODIPINE BESYLATE 774 646 3 2
LEVOTHYROXINE SODIUM 698 559 4 5
OMEPRAZOLE 604 473 5 3
METFORMIN HCL 443 367 6 6
ATENOLOL 409 373 7 10
GLIPIZIDE 387 313 8 41
METOPROLOL TARTRATE 364 288 9 7
LOVASTATIN 352 315 10 21
HYDROCHLOROTHIAZIDE 318 259 11 9
FUROSEMIDE 311 267 12 8
MELOXICAM 301 266 13 33
ALENDRONATE SODIUM 270 234 14 23
HYDROCODONE-ACETAMINOPHEN 255 171 S3 15 12
ALPRAZOLAM 236 168 16 31
ENALAPRIL MALEATE 222 186 17 35
GEMFIBROZIL 212 146 18 82
BACLOFEN 202 159 19 97
TRAMADOL HCL 199 134 20 22
WARFARIN SODIUM 195 190 21 15
TEMAZEPAM 189 178 22 47
CLOPIDOGREL 187 173 23 26
ISOSORBIDE MONONITRATE ER 185 180 24 56
DICLOFENAC SODIUM 180 140 25 86
LOSARTAN POTASSIUM 179 157 26 11
SERTRALINE HCL 175 107 27 27
DONEPEZIL HCL 175 171 27 30
GABAPENTIN 172 141 29 17
CARVEDILOL 161 130 30 20
NAPROXEN 153 130 31 70
ZOLPIDEM TARTRATE 151 100 32 14
PLAVIX 150 140 33 39
PROAIR HFA 140 68 34 62
AZITHROMYCIN 138 98 35 34
POTASSIUM CHLORIDE 132 106 36 24
CALCITRIOL 119 106 37 265
ATORVASTATIN CALCIUM 117 107 38 13
NIFEDIPINE ER 114 93 39 67
TRIAMTERENE-HCTZ 114 92 39 58
AMOXICILLIN 108 69 41 133
EXFORGE 107 85 42 198
RANITIDINE HCL 100 57 43 29
ALLOPURINOL 91 88 44 37
INSULIN SYRINGE 90 76 45 76
VERAPAMIL ER 88 78 46 99
METHYLPREDNISOLONE 88 70 46 78
LOVAZA 87 71 48 117
TAMSULOSIN HCL 84 70 49 28
CLONIDINE HCL 84 70 49 46
SYNTHROID 83 78 51 42
PRAVASTATIN SODIUM 83 55 51 16
IBUPROFEN 83 43 51 55
LORAZEPAM 81 49 54 73
GLYBURIDE 79 74 R 55 54
DIOVAN HCT 79 57 55 80
CIPROFLOXACIN HCL 78 57 57 53
CRESTOR 78 36 57 19
FLUTICASONE PROPIONATE 77 68 59 32
DIOVAN 77 61 59 40
GLIPIZIDE ER 75 75 61 112
ENDOCET 72 13 S2 62 269
DIGOXIN 71 59 63 51
CAPTOPRIL 69 69 64 193
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 22 65 36
SPIRONOLACTONE 68 65 65 77
DIAZEPAM 66 43 67 214
FLUOXETINE HCL 66 44 67 68
METOPROLOL SUCCINATE 65 65 69 18
OXYCODONE-ACETAMINOPHEN 62 19 S2 70 91
ADVAIR DISKUS 62 43 70 52
PANTOPRAZOLE SODIUM 60 51 72 38
OXYBUTYNIN CHLORIDE 58 56 73 107
NIFEDICAL XL 58 38 73 221
LANTUS 57 47 75 59
OXYCODONE HCL-ACETAMINOPHEN 56 25 S2 76 104
NOVOLOG MIX 70-30 FLEXPEN 54 21 77 349
KLOR-CON 10 52 50 78 106
DOXAZOSIN MESYLATE 52 48 78 57
LOSARTAN-HYDROCHLOROTHIAZIDE 51 38 80 48
CILOSTAZOL 51 41 80 168
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.